1. Home
  2. FBIO vs EEA Comparison

FBIO vs EEA Comparison

Compare FBIO & EEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBIO
  • EEA
  • Stock Information
  • Founded
  • FBIO 2006
  • EEA 1986
  • Country
  • FBIO United States
  • EEA Germany
  • Employees
  • FBIO N/A
  • EEA N/A
  • Industry
  • FBIO Biotechnology: Pharmaceutical Preparations
  • EEA Trusts Except Educational Religious and Charitable
  • Sector
  • FBIO Health Care
  • EEA Finance
  • Exchange
  • FBIO Nasdaq
  • EEA Nasdaq
  • Market Cap
  • FBIO 58.3M
  • EEA 67.9M
  • IPO Year
  • FBIO N/A
  • EEA N/A
  • Fundamental
  • Price
  • FBIO $1.97
  • EEA $10.38
  • Analyst Decision
  • FBIO Strong Buy
  • EEA
  • Analyst Count
  • FBIO 2
  • EEA 0
  • Target Price
  • FBIO $21.00
  • EEA N/A
  • AVG Volume (30 Days)
  • FBIO 219.9K
  • EEA 9.2K
  • Earning Date
  • FBIO 08-12-2025
  • EEA 01-01-0001
  • Dividend Yield
  • FBIO N/A
  • EEA 1.92%
  • EPS Growth
  • FBIO N/A
  • EEA N/A
  • EPS
  • FBIO N/A
  • EEA N/A
  • Revenue
  • FBIO $57,784,000.00
  • EEA N/A
  • Revenue This Year
  • FBIO $51.59
  • EEA N/A
  • Revenue Next Year
  • FBIO $44.74
  • EEA N/A
  • P/E Ratio
  • FBIO N/A
  • EEA N/A
  • Revenue Growth
  • FBIO N/A
  • EEA N/A
  • 52 Week Low
  • FBIO $1.33
  • EEA $7.45
  • 52 Week High
  • FBIO $2.66
  • EEA $9.26
  • Technical
  • Relative Strength Index (RSI)
  • FBIO 55.60
  • EEA 60.68
  • Support Level
  • FBIO $1.90
  • EEA $10.09
  • Resistance Level
  • FBIO $2.02
  • EEA $10.51
  • Average True Range (ATR)
  • FBIO 0.10
  • EEA 0.12
  • MACD
  • FBIO -0.00
  • EEA -0.00
  • Stochastic Oscillator
  • FBIO 72.73
  • EEA 69.05

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

About EEA The European Equity Fund Inc.

European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.

Share on Social Networks: